Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Umbrella Alt Text Close
  • ASH Clinical News
  • ASH News Daily
  • ASH-SAP
  • Blood Journals
    • Blood
    • Blood Advances
    • Blood Global Hematology
    • Blood Immunology & Cellular Therapy
    • Blood Neoplasia
    • Blood Red Cells & Iron
    • Blood Vessels, Thrombosis & Hemostasis
  • Hematology
  • The Hematologist
  • International
    • Blood Chinese Edition
    • Blood Italian Edition
    • Blood Latin America Edition
    • Blood Spanish Edition
  • ASH
    • ASH Home
    • Research
    • Education
    • Advocacy
    • Meetings
    • Publications
    • ASH Store
Cart
User Tools Dropdown
Cart
Sign In
Search Dropdown Menu
header search
    Search
    ASH Clinical News
    Toggle MenuMenu
    • About
      • About
      • Editorial Board and Staff
      • Current Issue
      • Past Issues
      • Advertising
      • Subscribe
      • ASH Publications App
      • Contact Us
    • Viewpoints
      • From the Desk Of… Videos
      • Editor's Corner
      • Advanced Practice Voices
      • Notes from the Hill
      • A Day in the Life
      • Letters to the Editor
    • Education
      • You Make the Call
      • You Make the Call: Reader's Response
      • Hematologica Obscura
      • How I Treat: In Brief
      • Demystifying the Lab
      • Practice Update
      • Algorithms in Hematology
      • Webinars
    • Spotlight
      • Feature Articles
      • Blood Beyond Borders
      • pASHions
      • Pulling Back the Curtain
      • Drawing First Blood
    • News
      • On Location
      • On Location Videos
      • In a Different Vein: News From the Blood Journals Portfolio
      • Literature Scan
      • Latest and Greatest
      • ASH Directions
      • Society Pages
      • Data Stream
    • Topic Compilations
      • Acute Leukemias
      • Chronic Leukemias
      • MDS and Myeloproliferative Neoplasms
      • Lymphomas and Lymphoid Neoplasia
      • Bleeding Disorders
      • Clotting Disorders
      • Multiple Myeloma and Plasma Disorders
      • Red Blood Cell and Iron Disorders
    Skip Nav Destination
    Update search
    Querybuilder input 1
    Filter
    • Title
    • Author
    • Full Text
    • Abstract
    • Keyword
    • DOI
    Querybuilder input 2
    Filter
    • Title
    • Author
    • Full Text
    • Abstract
    • Keyword
    • DOI
    Querybuilder input 3
    Filter
    • Title
    • Author
    • Full Text
    • Abstract
    • Keyword
    • DOI
    Querybuilder input 4
    Filter
    • Title
    • Author
    • Full Text
    • Abstract
    • Keyword
    • DOI
    Querybuilder input 5
    Filter
    • Title
    • Author
    • Full Text
    • Abstract
    • Keyword
    • DOI
    Querybuilder input 6
    Filter
    • Title
    • Author
    • Full Text
    • Abstract
    • Keyword
    • DOI

    NARROW

    Publications
    Filter by publications
    Format
    Filter by format
    Topics
    Filter by topics
    Date
    Filter by date
    Apply
    Availability
    Availability
    1-7 of 7
    Sort by
    News

    Early Data Show EZH2 Inhibitor Active in Non-Hodgkin Lymphoma

    Published: 2021
    View News titled, Early Data Show EZH2 Inhibitor Active in Non-Hodgkin Lymphoma
    News

    Potent Small-Molecule BCL6 Inhibitor Active against ABC-, GCB-DLBCL Cells

    Published: 2021
    View News titled, Potent Small-Molecule BCL6 Inhibitor Active against ABC-, GCB-DLBCL Cells
    News

    Mechanisms of Ibrutinib Resistance Varied in ABC DLBCL

    Published: 2021
    View News titled, Mechanisms of Ibrutinib Resistance Varied in ABC DLBCL
    News

    ASH Meeting on Lymphoma Biology: Creating a Roadmap for Future Research

    Published: 2021
    View News titled, ASH Meeting on Lymphoma Biology: Creating a Roadmap for Future Research
    News

    Tazemetostat for Patients with Pretreated Non-Hodgkin Lymphoma

    Published: 2021
    View News titled, Tazemetostat for Patients with Pretreated Non-Hodgkin Lymphoma
    News

    R-EPOCH May Be Viable Option for Patients with High-Risk DLBCL

    Published: 2021
    View News titled, R-EPOCH May Be Viable Option for Patients with High-Risk DLBCL
    News

    Ibrutinib Shows Survival Benefit in Previously Treated CLL/SLL Patients with High-Risk Disease

    Published: 2021
    View News titled, Ibrutinib Shows Survival Benefit in Previously Treated CLL/SLL Patients with High-Risk Disease
    ASH Clinical News
    • About ASH Clinical News
    • Advertising
    • Subscribe
    • Contact Us
    • ASH Publications App
    • American Society of Hematology
    • 2021 L Street NW, Suite 900
    • Washington, DC 20036
    • TEL +1 202-776-0544
    • FAX +1 202-776-0545
    American Society of Hematology

    ASH Publications

    • Blood
    • Blood Advances
    • Blood Global Hematology
    • Blood Neoplasia
    • Blood Vessels, Thrombosis & Hemostasis
    • Hematology, ASH Education Program
    • ASH Clinical News
    • ASH-SAP
    • The Hematologist

    American Society of Hematology

    • ASH Home
    • Research
    • Education
    • Advocacy
    • Meetings
    • Publications
    • ASH Store
    Copyright 2024 by American Society of Hematology
     
    • Cookie Settings
    • Privacy Policy
    • Cookie Policy
    • Terms of Use
    • Contact Us
    Close Modal
    Close Modal
    This Feature Is Available To Subscribers Only

    Sign In or Create an Account

    Close Modal
    Close Modal

    Advertisement intended for health care professionals